A clinical drug library screen identifies clobetasol propionate as an NRF2 inhibitor with potential therapeutic efficacy in KEAP1 mutant lung cancer
2017
A clinical drug library screen identifies clobetasol propionate as an NRF2 inhibitor with potential therapeutic efficacy in KEAP1 mutant lung cancer
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
57
References
56
Citations
NaN
KQI